<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical evidence: In a double-blind, placebo-controlled trial in 38 healthy volunteers (ages 18–60 years), single dose of 300 mg 
 <italic>B. monniera</italic> extract (containing 55% combined bacosides A and B) did not cause any significant change in cognitive function at 2 h [
 <xref rid="B87-brainsci-10-00964" ref-type="bibr">87</xref>]. However, six week 
 <italic>Bacopa</italic> administration (300 mg for subjects under 90 kg, and 450 mg for subjects over 90 kg, equivalent to 6 g and 9 g dried rhizome, respectively) in a double-blind, randomized, placebo controlled fashion was associated with significant improvement in retention of new information in 40–65 year old healthy adults. Though there was no difference in the rate of acquisition of information [
 <xref rid="B88-brainsci-10-00964" ref-type="bibr">88</xref>].
</p>
